{
    "2021-09-13": [
        [
            {
                "time": "",
                "original_text": "睿智医药业务跨越堪比药明康德，为何却是行业倒数第二？",
                "features": {
                    "keywords": [
                        "睿智医药",
                        "药明康德",
                        "行业倒数"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医药板块迎来布局窗口",
                "features": {
                    "keywords": [
                        "医药生物",
                        "布局窗口"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中小盘IPO专题-次新股说：本批百普赛斯等值得重点跟踪(2021批次34、35)",
                "features": {
                    "keywords": [
                        "中小盘IPO",
                        "百普赛斯",
                        "重点跟踪"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业中报透视CXO：板块增长强劲 边际变化持续向好",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "板块增长",
                        "边际变化向好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业点评：本周板块企稳 建议关注胰岛素和人工关节集采",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块企稳",
                        "胰岛素",
                        "人工关节集采"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}